safingol and Thrombopenia

safingol has been researched along with Thrombopenia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Casper, ES; Kelsen, DP; Mullen, E; Saltz, L; Schwartz, GK; Spiess, T; Storniolo, AM; Venuti, R; Ward, D; Woodworth, J; Zervos, P1

Trials

1 trial(s) available for safingol and Thrombopenia

ArticleYear
A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Enzyme Inhibitors; Female; Humans; Infusions, Intravenous; Leukopenia; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Pilot Projects; Protein Kinase C; Regression Analysis; Sphingosine; Thrombocytopenia

1997